NM_031885.5:c.1422G>A

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4BP6BP7BS1BS2

The NM_031885.5(BBS2):​c.1422G>A​(p.Ser474Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00338 in 1,613,978 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S474S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 11 hom. )

Consequence

BBS2
NM_031885.5 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:11

Conservation

PhyloP100: 2.13

Publications

4 publications found
Variant links:
Genes affected
BBS2 (HGNC:967): (Bardet-Biedl syndrome 2) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014]
BBS2 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • BBS2-related ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 74
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.15).
BP6
Variant 16-56499883-C-T is Benign according to our data. Variant chr16-56499883-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 194124.
BP7
Synonymous conserved (PhyloP=2.13 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0024 (366/152214) while in subpopulation AMR AF = 0.00576 (88/15288). AF 95% confidence interval is 0.00479. There are 0 homozygotes in GnomAd4. There are 185 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 11 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_031885.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS2
NM_031885.5
MANE Select
c.1422G>Ap.Ser474Ser
synonymous
Exon 12 of 17NP_114091.4
BBS2
NM_001377456.1
c.1422G>Ap.Ser474Ser
synonymous
Exon 12 of 18NP_001364385.1Q9BXC9
BBS2
NR_165293.1
n.1584G>A
non_coding_transcript_exon
Exon 12 of 17

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS2
ENST00000245157.11
TSL:1 MANE Select
c.1422G>Ap.Ser474Ser
synonymous
Exon 12 of 17ENSP00000245157.5Q9BXC9
BBS2
ENST00000565781.6
TSL:1
n.3744G>A
non_coding_transcript_exon
Exon 8 of 12
ENSG00000288725
ENST00000684388.1
n.342G>A
non_coding_transcript_exon
Exon 3 of 14ENSP00000507647.1A0A804HJU2

Frequencies

GnomAD3 genomes
AF:
0.00241
AC:
366
AN:
152096
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000580
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00576
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00344
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00221
AC:
557
AN:
251468
AF XY:
0.00237
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.00205
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.000554
Gnomad NFE exome
AF:
0.00375
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00348
AC:
5089
AN:
1461764
Hom.:
11
Cov.:
30
AF XY:
0.00347
AC XY:
2521
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.000358
AC:
12
AN:
33478
American (AMR)
AF:
0.00201
AC:
90
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39688
South Asian (SAS)
AF:
0.000997
AC:
86
AN:
86240
European-Finnish (FIN)
AF:
0.000580
AC:
31
AN:
53406
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00422
AC:
4690
AN:
1111944
Other (OTH)
AF:
0.00290
AC:
175
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
271
542
813
1084
1355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00240
AC:
366
AN:
152214
Hom.:
0
Cov.:
32
AF XY:
0.00249
AC XY:
185
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.000578
AC:
24
AN:
41510
American (AMR)
AF:
0.00576
AC:
88
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4822
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00344
AC:
234
AN:
68024
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00258
Hom.:
2
Bravo
AF:
0.00233
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00360
EpiControl
AF:
0.00338

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
1
2
Bardet-Biedl syndrome 2 (3)
-
-
2
Bardet-Biedl syndrome 1 (2)
-
-
1
Bardet-Biedl syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.15
CADD
Benign
14
DANN
Benign
0.72
PhyloP100
2.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117033008; hg19: chr16-56533795; COSMIC: COSV104392646; API